At Dr. Reddy's, our aim is to help people lead healthier lives through two parallel objectives: delivering affordable and accessible medication to all parts of the world; and discovering, developing and commercializing innovative medicines that satisfy unmet medical needs.

Headquartered in India, we are a global pharmaceutical company with a presence in more than 100 countries. We have wholly-owned subsidiaries in the US, UK, Russia, Germany and Brazil; joint ventures in China, South Africa and Australia; representative offices in 16 countries; and third-party distribution set ups in 21 countries. Dr. Reddy’s is the first pharmaceutical company in Asia outside of Japan to be listed on the NYSE.

Our strong portfolio of businesses, geographies and products gives us an edge in an increasingly competitive global market and allows us to provide affordable medication to people across the world, regardless of geographic and socio-economic barriers.